| Description |
1 online resource (128 pages) |
| Contents |
FOREWORD 1 ; FOREWORD 2; FOREWORD 2; PREFACE ; List of Contributors ; Public-Private Partnerships in Biobanking: Current Practices ; Manuel M. Morente*, Francisco de Luna, Maria C. Marín and Nuria Ajenjo; INTRODUCTION: THE CHALLENGE OF PERSONALISED MEDICINE; PUBLIC-PRIVATE RELATIONSHIPS: A NON-HOMOGENEOUS MODEL; THE PRIVATE AND THE PUBLIC SECTOR: TWO SECTORS WITH SPECIFIC OBJECTIVES, RESOURCES AND SKILLS; PPPS AND BIOBANK SUSTAINABILITY; THE STAKEHOLDERS; PUBLIC SECTOR AND NON-PROFIT AGENCIES; INDUSTRY; PUBLIC BIOBANKS AND BIOBANK NETWORKS; DONORS |
|
BASES OF A FRUITFUL PPPS IN BIOBANKING"WHY" PPP IS MORE IMPORTANT THAN "HOW" WE SHOULD DO IT; CONFLICT OF INTEREST; ACKNOWLEDGEMENT; REFERENCES; Models of Collaboration and Experiences between Bio-Industry and Academic Biobanks ; Rita T. Lawlor* and Aldo Scarpa; INTRODUCTION; PPP COLLABORATORS; Academic Biobank Structures; Industry Partner; Small and Medium Enterprises; Government & Public; ELEMENTS TO BE ADDRESSED IN MODELS OF COLLABORATION; Different Goals; Different Concepts of Time; IP and other Returns; Different Concepts of Collaborations and Contracts; Conflict of Interest |
|
Public TrustRecruitment of Patients; Privacy Issues, Data Sharing and Requirements for Additional Oversight; Incidental Findings; Issues of Quality; The Shift to Data; BASIC MODELS OF COLLABORATION; Service Based Collaboration; Advantages; Limitations; Research Collaboration Agreement; Advantages; Limitations; Moving to a One to Many Situation; Onconetwork Consortium; Data Access is Easier in Validation Studies; Validation Studies Rarely Have Intellectual Property Issues; Academia Advantage; Industry Advantage; Limitations; Need For Modification of Models Of Collaboration |
|
BIOBANK SPECIFIC MODELS OF COLLABORATIONBroker Model; One Size Fits Alls; The Honest Broker; Limitations in Accessing Standard Data; National Broker Model; Lifandis; Public -- Private National/Population Biobank Model; Danish National Biobank Example; The UK Biobank Example; Public Trust; NEW MODELS OF COLLABORATION; Expert Center Model; BBMRI Expert Centres; An Expansion of Other Models; A Specific Networked Example Of A BBMRI Expert Center; Advantages and Limitations; UMBRELLA INITIATIVES; The Innovative Medicines Initiative (IMI); Ticking All The Boxes; TURNING THE TABLES |
|
Cancer Cell Line Encyclopedia (CCLE)Academic Drug Discovery Centers; Academic Drug Discovery Consortium (ADDC); THE WAY FORWARD; CONCLUDING REMARKS; CONFLICT OF INTEREST; ACKNOWLEDGEMENT; REFERENCES; Quality Management System for Research Biobanks: a Tool to Incentivize Public-Private Partnerships ; Elena Bravo* and Mariarosaria Napolitano; 1. QUALITY REQUIREMENTS: A BRIDGE BETWEEN PUBLIC AND PRIVATE SECTORS; 1.1. From the Roots of Quality to Management System Standard(s) [MSS]; 1.2. Biobanking Worldwide: State of Art; 1.3. Quality and Biobanking; 2. STANDARD, CERTIFICATION AND ACCREDITATION |
| Bibliography |
Includes bibliographical references and index |
| Notes |
2.1. Formal Standard |
|
Print version record |
| Subject |
Biobanks -- Management
|
|
Biobanks -- Moral and ethical aspects
|
|
Human genetics.
|
|
Preservation of organs, tissues, etc.
|
|
SCIENCE -- Life Sciences -- Biochemistry.
|
|
Human genetics
|
|
Preservation of organs, tissues, etc.
|
| Form |
Electronic book
|
| Author |
Salvaterra, Elena
|
|
Corfield, Julie
|
| ISBN |
1681085100 |
|
9781681085104 |
|
